HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jiankang Liu Selected Research

Thioctic Acid (Lipoic Acid)

1/2021Htd2 deficiency-associated suppression of α-lipoic acid production provokes mitochondrial dysfunction and insulin resistance in adipocytes.
4/2014Reloading functionally ameliorates disuse-induced muscle atrophy by reversing mitochondrial dysfunction, and similar benefits are gained by administering a combination of mitochondrial nutrients.
1/2010Combined R-alpha-lipoic acid and acetyl-L-carnitine exerts efficient preventative effects in a cellular model of Parkinson's disease.
8/2009The effect of acetyl-L-carnitine and R-alpha-lipoic acid treatment in ApoE4 mouse as a model of human Alzheimer's disease.
7/2008Protective effects of R-alpha-lipoic acid and acetyl-L-carnitine in MIN6 and isolated rat islet cells chronically exposed to oleic acid.
1/2008The effects and mechanisms of mitochondrial nutrient alpha-lipoic acid on improving age-associated mitochondrial and cognitive dysfunction: an overview.
6/2007D-galactose toxicity in mice is associated with mitochondrial dysfunction: protecting effects of mitochondrial nutrient R-alpha-lipoic acid.
1/2007Acrolein, a toxicant in cigarette smoke, causes oxidative damage and mitochondrial dysfunction in RPE cells: protection by (R)-alpha-lipoic acid.
8/2006Chronic systemic D-galactose exposure induces memory loss, neurodegeneration, and oxidative damage in mice: protective effects of R-alpha-lipoic acid.
6/2006Chronic systemic D-galactose exposure induces memory loss, neurodegeneration, and oxidative damage in mice: protective effects of R-alpha-lipoic acid.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jiankang Liu Research Topics

Disease

45Mitochondrial Diseases (Mitochondrial Disease)
01/2021 - 02/2002
21Neoplasms (Cancer)
01/2022 - 01/2011
20Insulin Resistance
02/2022 - 11/2009
19Heart Failure
01/2022 - 08/2015
15Hypertension (High Blood Pressure)
01/2021 - 03/2003
12Cognitive Dysfunction
11/2021 - 02/2002
12Obesity
01/2021 - 03/2003
11Inflammation (Inflammations)
12/2021 - 01/2013
11Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2020 - 06/2008
10Type 2 Diabetes Mellitus (MODY)
01/2021 - 01/2015
10Neuroblastoma
07/2017 - 08/2006
9Alzheimer Disease (Alzheimer's Disease)
01/2022 - 01/2008
8Myocardial Infarction
01/2022 - 04/2011
8Body Weight (Weight, Body)
01/2020 - 06/2008
7Carcinogenesis
01/2022 - 12/2010
7Parkinson Disease (Parkinson's Disease)
01/2021 - 07/2008
6Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 07/2010
6Macular Degeneration (Age-Related Maculopathy)
01/2020 - 01/2007
5Neurodegenerative Diseases (Neurodegenerative Disease)
12/2021 - 10/2009
5Stroke (Strokes)
01/2019 - 01/2010
4Melanoma (Melanoma, Malignant)
01/2021 - 01/2014
4Hyperlipidemias (Hyperlipidemia)
11/2020 - 10/2014
4Necrosis
06/2018 - 06/2010
4Coronary Disease (Coronary Heart Disease)
11/2017 - 06/2008
3Prostatic Neoplasms (Prostate Cancer)
01/2022 - 07/2013
3Fatty Liver
12/2019 - 04/2014
3Infections
12/2019 - 01/2018
3Psoriasis (Pustulosis Palmaris et Plantaris)
01/2019 - 01/2018
3Myocardial Ischemia (Ischemic Heart Diseases)
01/2019 - 06/2012
3Heart Arrest (Cardiac Arrest)
10/2018 - 03/2015
3Non-alcoholic Fatty Liver Disease
03/2016 - 10/2014
3Muscular Atrophy (Muscle Atrophy)
01/2016 - 05/2011
3Colonic Neoplasms (Colon Cancer)
08/2014 - 01/2012
3Memory Disorders (Memory Loss)
08/2006 - 02/2002
2Stomach Neoplasms (Stomach Cancer)
03/2022 - 01/2015
2Cardiomyopathies (Cardiomyopathy)
01/2022 - 06/2012
2Dementia (Dementias)
01/2021 - 11/2011

Drug/Important Bio-Agent (IBA)

30Proteins (Proteins, Gene)FDA Link
02/2022 - 02/2002
17Glucose (Dextrose)FDA LinkGeneric
01/2022 - 11/2006
15EnzymesIBA
01/2022 - 02/2002
13LipidsIBA
01/2021 - 08/2010
12Reactive Oxygen Species (Oxygen Radicals)IBA
12/2018 - 01/2010
11Triglycerides (Triacylglycerol)IBA
01/2021 - 06/2008
11Thioctic Acid (Lipoic Acid)IBA
01/2021 - 02/2002
113,4-dihydroxyphenylethanol (hydroxytyrosol)IBA
11/2016 - 12/2007
9Insulin (Novolin)FDA Link
01/2020 - 11/2006
9AntioxidantsIBA
01/2019 - 12/2007
9Acrolein (Aqualin)IBA
03/2015 - 06/2006
8LeptinIBA
03/2020 - 02/2006
7HydrogenIBA
07/2022 - 01/2016
7Retinal Pigments (Pigments, Visual)IBA
01/2020 - 01/2007
6Olive OilIBA
01/2021 - 07/2010
6Mineralocorticoid Receptor AntagonistsIBA
12/2020 - 01/2017
6Spironolactone (Aldactone)FDA LinkGeneric
12/2020 - 01/2017
6Acetylcarnitine (Alcar)IBA
04/2014 - 02/2002
6Oxidants (Oxidizing Agents)IBA
05/2011 - 01/2007
5Biomarkers (Surrogate Marker)IBA
03/2022 - 12/2010
5punicalaginIBA
02/2022 - 10/2014
5CytokinesIBA
01/2021 - 01/2014
5sacubitril and valsartan sodium hydrate drug combinationIBA
01/2021 - 08/2015
5AdiponectinIBA
03/2020 - 11/2011
5Adenosine Triphosphate (ATP)IBA
12/2019 - 07/2008
4CholesterolIBA
12/2020 - 10/2014
4DNA (Deoxyribonucleic Acid)IBA
01/2020 - 02/2002
4Neprilysin (Neutral Endopeptidase)IBA
10/2018 - 11/2010
4Galactose (Galactopyranose)FDA LinkGeneric
03/2014 - 06/2006
4Pharmaceutical PreparationsIBA
02/2014 - 11/2009
4HDL CholesterolIBA
01/2013 - 06/2008
3Therapeutic UsesIBA
07/2022 - 06/2014
3LipopolysaccharidesIBA
07/2022 - 01/2014
3DiureticsIBA
01/2022 - 01/2016
3Brain Natriuretic Peptide (Natrecor)FDA Link
01/2022 - 10/2013
3EnalaprilFDA LinkGeneric
01/2021 - 08/2015
3Hypoglycemic Agents (Hypoglycemics)IBA
01/2021 - 06/2008
3Mitochondrial DNA (mtDNA)IBA
01/2021 - 02/2015
3Ligases (Synthetase)IBA
10/2020 - 01/2016
3UbiquitinIBA
10/2020 - 01/2010
3Messenger RNA (mRNA)IBA
01/2020 - 07/2008
3Malondialdehyde (Propanedial)IBA
01/2020 - 06/2006
3PalmitatesIBA
12/2019 - 10/2014
3Imiquimod (Aldara)FDA LinkGeneric
01/2019 - 01/2018
3Amyloid (Amyloid Fibrils)IBA
12/2018 - 11/2016
3Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
05/2018 - 08/2015
3Superoxides (Superoxide)IBA
04/2016 - 07/2013
3ResveratrolIBA
01/2016 - 01/2016
3CurcuminIBA
03/2014 - 11/2013
3SmokeIBA
12/2010 - 01/2007
3alpha-SynucleinIBA
04/2010 - 07/2008
2Oxygen (Dioxygen)IBA
07/2022 - 01/2016
2ORALIT (ORS)IBA
03/2022 - 06/2008
2Dynamins (Dynamin)IBA
01/2022 - 12/2020
2Deubiquitinating EnzymesIBA
01/2022 - 12/2020
2Amyloid beta-PeptidesIBA
11/2021 - 11/2010
2PotassiumIBA
01/2021 - 05/2018
2LDL Lipoproteins (beta Lipoproteins)IBA
01/2021 - 01/2018
2paragonIBA
01/2021 - 01/2021
2omecamtiv mecarbilIBA
01/2021 - 12/2020
2Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2021 - 01/2020

Therapy/Procedure

17Therapeutics
01/2022 - 12/2008
3Mediterranean Diet
11/2016 - 07/2010